HIV molecular immunology database

 

Search CTL/CD8+ T-Cell Epitope Database

Found 1 matching record:

Displaying record number 56296

Download this epitope record as JSON.

HXB2 Location Gag(20-28)
p17(20-28)
DNA(847..873)
Gag Epitope Map
Author Location p17(20-28 SF2, HXBc2/Bal R5)
Epitope RLRPGGKKK Epitope Alignment
RLRPGGKKK epitope logo
Show epitope variants
Epitope Name RK9
Subtype B
Species (MHC/HLA) human(A3, B7)
Immunogen HIV-1 infection
Patient MHC/HLA A2, A3, B15, B7, Cw3, Cw6; A29, A3, B44, B7, Cw3, Cw7; A24, A3, B7, B8, Cw7
Country United States
Experimental methods Cytokine production, Degranulation, CD107a and b cell surface mobilization, Flow cytometric T-cell cytokine assay
Keywords supervised treatment interruptions (STI), immunodominance, variant cross-reactivity, characterizing CD8+ T cells, drug resistance

Notes

References

Daucher2008 Marybeth Daucher, David A. Price, Jason M. Brenchley, Laurie Lamoreaux, Julia A. Metcalf, Catherine Rehm, Elizabeth Nies-Kraske, Elizabeth Urban, Christian Yoder, Diane Rock, Julie Gumkowski, Michael R. Betts, Mark R. Dybul, and Daniel C. Douek. Virological Outcome after Structured Interruption of Antiretroviral Therapy for Human Immunodeficiency Virus Infection Is Associated with the Functional Profile of Virus-Specific CD8+ T Cells. J. Virol., 82(8):4102-4114, Apr 2008. PubMed ID: 18234797. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health